{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T23:49:06Z","timestamp":1778802546464,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1136\/ijgc-2022-003728","type":"journal-article","created":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T20:00:24Z","timestamp":1660852824000},"page":"1115-1122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["The increasing incidence of stage IV cervical cancer in the USA: what factors are related?"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8606-6817","authenticated-orcid":false,"given":"Alex Andrea","family":"Francoeur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-I","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle Ann","family":"Casear","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ava","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel S","family":"Kapp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9454-3254","authenticated-orcid":false,"given":"Joshua G","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ritu","family":"Salani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John K","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2022-003728_bb0010","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1136\/ijgc-2022-003728_bb0015","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1016\/S0140-6736(03)13778-6","article-title":"Cervical cancer","volume":"361","author":"Waggoner","year":"2003","journal-title":"Lancet"},{"key":"10.1136\/ijgc-2022-003728_bb0020","first-page":"300","article-title":"Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the Advisory Committee on immunization practices","volume":"64","author":"Petrosky","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1136\/ijgc-2022-003728_bb0025","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","article-title":"HPV vaccination and the risk of invasive cervical cancer","volume":"383","author":"Lei","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2022-003728_bb0030","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA A Cancer J Clin"},{"key":"10.1136\/ijgc-2022-003728_bb0035","doi-asserted-by":"crossref","first-page":"213","DOI":"10.14423\/SMJ.0000000000000794","article-title":"A social-ecological review of cancer disparities in Kentucky","volume":"111","author":"Rodriguez","year":"2018","journal-title":"South Med J"},{"key":"10.1136\/ijgc-2022-003728_bb0040","doi-asserted-by":"crossref","first-page":"9719","DOI":"10.7314\/APJCP.2014.15.22.9719","article-title":"Health disparities between black Hispanic and black non-Hispanic cervical cancer cases in the USA","volume":"15","author":"Khan","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1136\/ijgc-2022-003728_bb0045","doi-asserted-by":"crossref","first-page":"5119","DOI":"10.1002\/cncr.30906","article-title":"Cervical cancer survival in the United States by race and stage (2001-2009): findings from the CONCORD-2 study","volume":"123","author":"Benard","year":"2017","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2022-003728_bb0050","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ypmed.2019.04.010","article-title":"Trends in cervical cancer incidence rates by age, race\/ethnicity, histological subtype, and stage at diagnosis in the United States","volume":"123","author":"Islami","year":"2019","journal-title":"Prev Med"},{"key":"10.1136\/ijgc-2022-003728_bb0055","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1093\/jnci\/djaa128","article-title":"Incidence trends and burden of human papillomavirus-associated cancers among women in the United States, 2001-2017","volume":"113","author":"Deshmukh","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"10.1136\/ijgc-2022-003728_bb0060","author":"CDC","year":"2021","journal-title":"U.S. cancer statistics public use databases"},{"key":"10.1136\/ijgc-2022-003728_bb0065","unstructured":"United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute . National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database: NPCR and SEER Incidence - U.S. Cancer Statistics 2001-2017 Public Use Research Database, 2019 Submission (2001-2017). Available: www.cdc.gov\/cancer\/uscs\/public-use"},{"key":"10.1136\/ijgc-2022-003728_bb0070","unstructured":"CDC - BRFSS . (2020, August 10). Behavioral risk factor surveillance system. Available: https:\/\/www.cdc.gov\/brfss\/"},{"key":"10.1136\/ijgc-2022-003728_bb0075","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1200\/EDBK_325319","article-title":"State of the science: screening, surveillance, and epidemiology of HPV-related malignancies","volume":"41","author":"Ghebre","year":"2021","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1136\/ijgc-2022-003728_bb0080","author":"CDC","year":"2017","journal-title":"TeenVaxView | coverage data source | TeenVaxView data source"},{"key":"10.1136\/ijgc-2022-003728_bb0085","author":"Howlader","year":"2021"},{"key":"10.1136\/ijgc-2022-003728_bb0090","author":"Race Recode Changes","year":"2005","journal-title":"Race Recode Changes - SEER Documentation"},{"key":"10.1136\/ijgc-2022-003728_bb0095","author":"CDC","year":"2021","journal-title":"Merged summary stage variable | U.S. cancer statistics public use database"},{"key":"10.1136\/ijgc-2022-003728_bb0100","year":"2021","journal-title":"Number of Joinpoints"},{"key":"10.1136\/ijgc-2022-003728_bb0105","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"147","author":"von Elm","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1136\/ijgc-2022-003728_bb0110","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/bs.acr.2016.09.001","article-title":"Disparities in cervical cancer incidence and mortality: can epigenetics contribute to eliminating disparities?","volume":"133","author":"Maguire","year":"2017","journal-title":"Adv Cancer Res"},{"key":"10.1136\/ijgc-2022-003728_bb0115","unstructured":"US National Institutes of Health, National Cancer Institute, Surveillance Epidemiology and End Results (SEER) . Cancer STAT fact sheets: cancer of the cervix uteri. Available: http:\/\/seer.cancer.gov\/statfacts\/html\/cervix.html"},{"key":"10.1136\/ijgc-2022-003728_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193047","article-title":"Insurance status and cancer treatment mediate the association between race\/ethnicity and cervical cancer survival","volume":"13","author":"Markt","year":"2018","journal-title":"PLoS One"},{"key":"10.1136\/ijgc-2022-003728_bb0125","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/AOG.0000000000001819","article-title":"Association of hospital volume with racial and ethnic disparities in locally advanced cervical cancer treatment","volume":"129","author":"Uppal","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-2022-003728_bb0130","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/gyno.2000.5826","article-title":"The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States--a 24-year population-based study","volume":"78","author":"Smith","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2022-003728_bb0135","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1038\/sj.bjc.6601754","article-title":"Lower protection of cytological screening for adenocarcinomas and shorter protection for younger women: the results of a case-control study in Florence","volume":"90","author":"Zappa","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1136\/ijgc-2022-003728_bb0140","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1479-828X.2007.00788.x","article-title":"Pap smear screening history of women with squamous cell carcinoma and adenocarcinoma of the cervix","volume":"47","author":"Pak","year":"2007","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1136\/ijgc-2022-003728_bb0145","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/ijc.22357","article-title":"Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies","volume":"120","author":"The International Collaboration of Epidemiological Studies of Cervical Cancer","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1136\/ijgc-2022-003728_bb0150","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","article-title":"2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors","volume":"24","author":"Perkins","year":"2020","journal-title":"J Low Genit Tract Dis"},{"key":"10.1136\/ijgc-2022-003728_bb0155","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/jnci\/djj067","article-title":"Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention","volume":"98","author":"Castellsagu\u00e9","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1136\/ijgc-2022-003728_bb0160","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/cncr.20064","article-title":"Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000","volume":"100","author":"Wang","year":"2004","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2022-003728_bb0165","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ijc.25396","article-title":"Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication","volume":"128","author":"Li","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1136\/ijgc-2022-003728_bb0170","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/jwh.2006.0161","article-title":"Understanding barriers for adherence to follow-up care for abnormal Pap tests","volume":"16","author":"Eggleston","year":"2007","journal-title":"J Womens Health"},{"key":"10.1136\/ijgc-2022-003728_bb0175","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.vaccine.2018.12.017","article-title":"Variations in reason for intention not to vaccinate across time, region, and by race\/ethnicity, NIS-Teen (2008-2016)","volume":"37","author":"Hirth","year":"2019","journal-title":"Vaccine"},{"key":"10.1136\/ijgc-2022-003728_bb0180","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/cncr.30507","article-title":"Hysterectomy\u2010corrected cervical cancer mortality rates reveal a larger racial disparity in the United States","volume":"123","author":"Beavis","year":"2017","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2022-003728_bb0185","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ygyno.2021.02.037","article-title":"Racial disparities in high-risk uterine cancer histologic subtypes: a United States cancer statistics study","volume":"161","author":"Abel","year":"2021","journal-title":"Gynecol Oncol"}],"updated-by":[{"DOI":"10.1136\/ijgc-2022-003728corr1","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000}},{"DOI":"10.1136\/ijgc-2022-003728corr2","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000}}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24008478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24008478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2022-003728","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:16:30Z","timestamp":1753229790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24008478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S1048891X24008478"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2022-003728","relation":{"erratum":[{"id-type":"doi","id":"10.1136\/ijgc-2022-003728corr2","asserted-by":"object"},{"id-type":"doi","id":"10.1136\/ijgc-2022-003728corr1","asserted-by":"object"}]},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The increasing incidence of stage IV cervical cancer in the USA: what factors are related?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2022-003728","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}